L3MBTL2 antibody (AA 208-701) (HRP)
Quick Overview for L3MBTL2 antibody (AA 208-701) (HRP) (ABIN8005429)
Target
See all L3MBTL2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 208-701
-
Purpose
- Anti-L3MBTL2 Antibody HRP Conjugated
-
Cross-Reactivity (Details)
- No cross reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human L3MBTL2 recombinant protein (Position: E208-Q701).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- L3MBTL2 (Lethal(3) Malignant Brain Tumor-Like Protein 2 (L3MBTL2))
-
Alternative Name
- L3MBTL2
-
Background
-
Background: Lethal(3)malignant brain tumor-like 2 protein is a protein that in humans is encoded by the L3MBTL2 gene. Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes,probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with achromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell intomitosis
Gene Full Name: L3MBTL histone methyl-lysine binding protein 2
-
Gene ID
- 83746
-
UniProt
- Q969R5
Target
-